Canada markets open in 5 hours 12 minutes

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.0700-0.0300 (-0.73%)
At close: 04:00PM EDT
4.1800 +0.12 (+2.96%)
After hours: 06:16PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 461.96M
Enterprise Value 250.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.29
Price/Book (mrq)1.25
Enterprise Value/Revenue 3.94
Enterprise Value/EBITDA -1.45

Trading Information

Stock Price History

Beta (5Y Monthly) 1.68
52-Week Change 3-24.77%
S&P500 52-Week Change 322.38%
52 Week High 38.8300
52 Week Low 31.6300
50-Day Moving Average 36.4068
200-Day Moving Average 34.0598

Share Statistics

Avg Vol (3 month) 32.62M
Avg Vol (10 day) 33.23M
Shares Outstanding 5113.78M
Implied Shares Outstanding 6113.82M
Float 880.65M
% Held by Insiders 11.46%
% Held by Institutions 193.62%
Shares Short (Apr 15, 2024) 418.92M
Short Ratio (Apr 15, 2024) 47.34
Short % of Float (Apr 15, 2024) 420.55%
Short % of Shares Outstanding (Apr 15, 2024) 416.63%
Shares Short (prior month Mar 15, 2024) 413.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -253.30%
Operating Margin (ttm)-2,098.75%

Management Effectiveness

Return on Assets (ttm)-18.32%
Return on Equity (ttm)-37.76%

Income Statement

Revenue (ttm)63.53M
Revenue Per Share (ttm)0.65
Quarterly Revenue Growth (yoy)-96.20%
Gross Profit (ttm)N/A
EBITDA -159.33M
Net Income Avi to Common (ttm)-160.93M
Diluted EPS (ttm)-1.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)315.18M
Total Cash Per Share (mrq)3.18
Total Debt (mrq)103.54M
Total Debt/Equity (mrq)28.10%
Current Ratio (mrq)8.48
Book Value Per Share (mrq)3.73

Cash Flow Statement

Operating Cash Flow (ttm)-132.26M
Levered Free Cash Flow (ttm)-74.25M